快而精医药(QGEN)

49.25 -1.10 -2.1847%

今开:49.31昨收:50.35
最高:49.61 最低:49.15
涨停价:0.0跌停价:0.0
总市值:1.1214225E10

快而精医药的热门评论

快而精医药(QGEN)2020-08-04 04:10

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-089609 Act: 34 Size: 129 KB 网页链接查看全文

快而精医药(QGEN)2020-08-04 04:35

$快而精医药(QGEN)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0000902664-20-002857 Act: 34 Size: 153 KB 网页链接查看全文

快而精医药(QGEN)2020-08-05 18:10

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-20-000043 Act: 34 Size: 1 MB 网页链接查看全文

快而精医药(QGEN)2020-08-05 18:15

$快而精医药(QGEN)$ SC 14D9/A [Amend] Solicitation, recommendation statements Accession Number: 0001193125-20-209618 Act: 34 Size: 312 KB 网页链接查看全文

快而精医药(QGEN)2020-08-05 18:10

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-20-000041 Act: 34 Size: 677 KB 网页链接查看全文

快而精医药(QGEN)2020-07-28 05:15

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-086884 Act: 34 Size: 127 KB 网页链接查看全文

快而精医药(QGEN)2020-07-23 21:30

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-085835 Act: 34 Size: 131 KB 网页链接查看全文

快而精医药(QGEN)2020-07-16 21:40

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-20-193770 Act: 34 Size: 94 KB 网页链接查看全文

chuminhua2020-07-18 15:49

7/16,COVID-19疫情提高了分子诊断产品的价值,Thermo Fisher Scientific$赛默飞世尔科技(TMO)$ 也提高了收购Qiagen$快而精医药(QGEN)$ 的报价10%。两家公司已经同意修改原来的115亿美元的收购要约条款。该收购要约于3月3日第一次公布,当时确诊的COVID-19病例少于10万,而今天已经是1,350万了。新...查看全文

快而精医药(QGEN)2020-07-21 04:10

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-084838 Act: 34 Size: 125 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

快而精医药的最新评论

财报披露

快而精医药(QGEN)11-09 19:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000047 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)11-09 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000042 Act: 34 Size: 7 MB 网页链接查看全文

财报披露

快而精医药(QGEN)11-09 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000045 Act: 34 Size: 544 KB 网页链接查看全文

财报披露

快而精医药(QGEN)07-29 18:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000040 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)07-28 18:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000037 Act: 34 Size: 533 KB 网页链接查看全文

专项披露公告

快而精医药(QGEN)06-01 18:06

$快而精医药(QGEN)$ SD Specialized disclosure report Accession Number: 0001015820-22-000031 Act: 34 Size: 44 KB 网页链接查看全文

财报披露

快而精医药(QGEN)04-29 18:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000026 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)04-28 18:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000024 Act: 34 Size: 443 KB 网页链接查看全文

定期披露文件

快而精医药(QGEN)03-14 19:36

$快而精医药(QGEN)$ IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Accession Number: 0001015820-22-000020 Act: 34 Size: 102 KB 网页链接查看全文

年度财报

快而精医药(QGEN)03-14 19:27

$快而精医药(QGEN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001015820-22-000017 Act: 34 Size: 24 MB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

快而精医药的公告

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000047 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000042 Act: 34 Size: 7 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000045 Act: 34 Size: 544 KB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000040 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000037 Act: 34 Size: 533 KB 网页链接

专项披露公告

$快而精医药(QGEN)$ SD Specialized disclosure report Accession Number: 0001015820-22-000031 Act: 34 Size: 44 KB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000026 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000024 Act: 34 Size: 443 KB 网页链接

定期披露文件

$快而精医药(QGEN)$ IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Accession Number: 0001015820-22-000020 Act: 34 Size: 102 KB 网页链接

年度财报

$快而精医药(QGEN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001015820-22-000017 Act: 34 Size: 24 MB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30